{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:50:28Z","timestamp":1787500228868,"version":"build-2736575974"},"reference-count":5,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2025,2,1]]},"abstract":"<jats:p>This post hoc analysis of 2 randomized clinical trials examines whether C-reactive protein estimated response to adalimumab in patients with hidradenitis suppurativa.<\/jats:p>","DOI":"10.1001\/jamadermatol.2024.5146","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T11:00:32Z","timestamp":1736334032000},"page":"221","source":"Crossref","is-referenced-by-count":1,"title":["C-Reactive Protein and Response to Adalimumab in Patients With Hidradenitis Suppurativa"],"prefix":"10.1001","volume":"161","author":[{"given":"Simon J.","family":"Gunter","sequence":"first","affiliation":[{"name":"Department of Medicine, Pennsylvania Hospital, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina L.","family":"Porter","sequence":"additional","affiliation":[{"name":"Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts"},{"name":"Department of Dermatology, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa B.","family":"Kimball","sequence":"additional","affiliation":[{"name":"Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts"},{"name":"Department of Dermatology, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"dld240029r1","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1056\/NEJMoa1504370","article-title":"Two phase 3 trials of adalimumab for hidradenitis suppurativa.","volume":"375","author":"Kimball","year":"2016","journal-title":"N Engl J Med"},{"issue":"10378","key":"dld240029r2","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0140-6736(23)00022-3","article-title":"Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials.","volume":"401","author":"Kimball","year":"2023","journal-title":"Lancet"},{"issue":"2","key":"dld240029r3","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/ced.14448","article-title":"Dermal tunnels influence time to clinical response and family history influences time to loss of clinical response in patients with hidradenitis suppurativa treated with adalimumab.","volume":"46","author":"Frew","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"dld240029r4","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/2450401","article-title":"The clinical significance of increased serum proinflammatory cytokines, C-reactive protein, and erythrocyte sedimentation rate in patients with hidradenitis suppurativa.","volume":"2017","author":"Jim\u00e9nez-Gallo","year":"2017","journal-title":"Mediators Inflamm"},{"issue":"6","key":"dld240029r5","doi-asserted-by":"publisher","first-page":"615","DOI":"10.36849\/JDD.6868","article-title":"Increased doses of adalimumab are associated with clinical improvement of hidradenitis suppurativa.","volume":"22","author":"Williams","year":"2023","journal-title":"J Drugs Dermatol"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2829086\/jamadermatology_gunter_2025_ld_240029_1739305490.17259.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T11:01:17Z","timestamp":1739962877000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2829086"}},"subtitle":["A Post Hoc Analysis of 2 Randomized Clinical Trials"],"short-title":[],"issued":{"date-parts":[[2025,2,1]]},"references-count":5,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2024.5146","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,1]]}}}